Very late-onset reactivation of retinopathy of prematurity post anti-VEGF bevacizumab treatment for type 1 ROP: a case report

Kirby Taylor; Layla Ghergherehchi; Prethy Rao; C. Armitage Harper; Emmanuel Chang

doi:10.1016/j.jaapos.2021.02.004

Very late-onset reactivation of retinopathy of prematurity post anti-VEGF bevacizumab treatment for type 1 ROP: a case report

Kirby Taylor, Layla Ghergherehchi, Prethy Rao, C. Armitage Harper, Emmanuel Chang

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

We report the case of 10-year-old girl who developed retinal neovascularization and vitreous hemorrhage 10 years after successful treatment of type 1 retinopathy of prematurity infant with intravitreal bevacizumab without laser ablation therapy.

Original language	English (US)
Pages (from-to)	180-184
Number of pages	5
Journal	Journal of AAPOS
Volume	25
Issue number	3
DOIs	https://doi.org/10.1016/j.jaapos.2021.02.004
State	Published - Jun 2021

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Ophthalmology

Access to Document

10.1016/j.jaapos.2021.02.004

Cite this

@article{f80c6df3b8ee49f58151f24f2dff1364,

title = "Very late-onset reactivation of retinopathy of prematurity post anti-VEGF bevacizumab treatment for type 1 ROP: a case report",

abstract = "We report the case of 10-year-old girl who developed retinal neovascularization and vitreous hemorrhage 10 years after successful treatment of type 1 retinopathy of prematurity infant with intravitreal bevacizumab without laser ablation therapy.",

author = "Kirby Taylor and Layla Ghergherehchi and Prethy Rao and Harper, {C. Armitage} and Emmanuel Chang",

note = "Publisher Copyright: {\textcopyright} 2021 American Association for Pediatric Ophthalmology and Strabismus",

year = "2021",

month = jun,

doi = "10.1016/j.jaapos.2021.02.004",

language = "English (US)",

volume = "25",

pages = "180--184",

journal = "Journal of AAPOS",

issn = "1091-8531",

publisher = "Mosby Inc.",

number = "3",

}

TY - JOUR

T1 - Very late-onset reactivation of retinopathy of prematurity post anti-VEGF bevacizumab treatment for type 1 ROP

T2 - a case report

AU - Taylor, Kirby

AU - Ghergherehchi, Layla

AU - Rao, Prethy

AU - Harper, C. Armitage

AU - Chang, Emmanuel

PY - 2021/6

Y1 - 2021/6

N2 - We report the case of 10-year-old girl who developed retinal neovascularization and vitreous hemorrhage 10 years after successful treatment of type 1 retinopathy of prematurity infant with intravitreal bevacizumab without laser ablation therapy.

AB - We report the case of 10-year-old girl who developed retinal neovascularization and vitreous hemorrhage 10 years after successful treatment of type 1 retinopathy of prematurity infant with intravitreal bevacizumab without laser ablation therapy.

UR - http://www.scopus.com/inward/record.url?scp=85108818391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85108818391&partnerID=8YFLogxK

U2 - 10.1016/j.jaapos.2021.02.004

DO - 10.1016/j.jaapos.2021.02.004

M3 - Article

C2 - 33964455

AN - SCOPUS:85108818391

SN - 1091-8531

VL - 25

SP - 180

EP - 184

JO - Journal of AAPOS

JF - Journal of AAPOS

IS - 3

ER -

Very late-onset reactivation of retinopathy of prematurity post anti-VEGF bevacizumab treatment for type 1 ROP: a case report

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this